| Company/Division name | Asahi Kasei Bioprocess America |
| Parent company | Asahi Kasei Corp |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2023 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | Glenview |
| State(s) reshored to: | IL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, Medical Equipment & Supplies |
| Product(s) reshored | bioprocess equipment |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Lead time/Time to market |
